tradingkey.logo


tradingkey.logo


Amneal Pharmaceuticals Inc

AMRX
11.850USD
-0.210-1.74%
終倀 03/27, 16:00ET15分遅れの株䟡
794.04M時䟡総額
51.54盎近12ヶ月PER


Amneal Pharmaceuticals Inc

11.850
-0.210-1.74%

詳现情報 Amneal Pharmaceuticals Inc 䌁業名

Amneal Pharmaceuticals, Inc. is a global pharmaceutical company, which develops, manufactures, markets and distributes a portfolio of essential medicines. Its Affordable Medicines segment includes a portfolio of over 280 product families covering a range of dosage forms and delivery systems, including both immediate and extended-release oral solids, powders, liquids, sterile injectables, nasal sprays, inhalation and respiratory products, biosimilar products, ophthalmic, films, transdermal patches and topicals. Its Specialty segment is engaged in the development, promotion, sale and distribution of branded pharmaceutical products, with a focus on products addressing central nervous system disorders, including Parkinson’s disease and endocrine disorders. Its AvKARE segment provides pharmaceuticals, medical and surgical products and services primarily to governmental agencies, predominantly focused on the U.S. Department of Defense and the U.S. Department of Veterans Affairs.

Amneal Pharmaceuticals Incの䌁業情報


䌁業コヌドAMRX
䌚瀟名Amneal Pharmaceuticals Inc
䞊堎日Nov 18, 2009
最高経営責任者「CEO」Patel (Chintu)
埓業員数8100
蚌刞皮類Ordinary Share
決算期末Nov 18
本瀟所圚地400 Crossing Boulevard, 3rd Floor
郜垂BRIDGEWATER
蚌刞取匕所NASDAQ OMX - NASDAQ BASIC
囜United States of America
郵䟿番号08807
電話番号19089473120
りェブサむトhttps://amneal.com/
䌁業コヌドAMRX
䞊堎日Nov 18, 2009
最高経営責任者「CEO」Patel (Chintu)

Amneal Pharmaceuticals Incの経営陣


䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Chintu Patel
Mr. Chintu Patel
Co-Chief Executive Officer, Co-Founder, Director
Co-Chief Executive Officer, Co-Founder, Director
26.14M
+2.01%
Mr. Gautam Patel
Mr. Gautam Patel
Director
Director
1.61M
-9.40%
Mr. Anastasios G. (Tasos) Konidaris
Mr. Anastasios G. (Tasos) Konidaris
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
621.88K
+24.36%
Ms. Nikita Shah
Ms. Nikita Shah
Chief Human Resources Officer, Executive Vice President
Chief Human Resources Officer, Executive Vice President
444.79K
+56.97%
Mr. Shlomo Yanai
Mr. Shlomo Yanai
Independent Director
Independent Director
285.99K
+14.08%
Ms. Deborah M. (Deb) Autor
Ms. Deborah M. (Deb) Autor
Independent Director
Independent Director
93.66K
+42.98%
Buchi (J Kevin)
Buchi (J Kevin)
Independent Director
Independent Director
--
--
Mr. Andrew S. Boyer
Mr. Andrew S. Boyer
Executive Vice President, Chief Commercial Officer - Generics
Executive Vice President, Chief Commercial Officer - Generics
--
--
Mr. Chirag Patel
Mr. Chirag Patel
President, Co-Chief Executive Officer, Co-Founder, Director
President, Co-Chief Executive Officer, Co-Founder, Director
--
--
Mr. Ted Nark
Mr. Ted Nark
Independent Director
Independent Director
--
--
詳现を芋る
䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Chintu Patel
Mr. Chintu Patel
Co-Chief Executive Officer, Co-Founder, Director
Co-Chief Executive Officer, Co-Founder, Director
26.14M
+2.01%
Mr. Gautam Patel
Mr. Gautam Patel
Director
Director
1.61M
-9.40%
Mr. Anastasios G. (Tasos) Konidaris
Mr. Anastasios G. (Tasos) Konidaris
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
621.88K
+24.36%
Ms. Nikita Shah
Ms. Nikita Shah
Chief Human Resources Officer, Executive Vice President
Chief Human Resources Officer, Executive Vice President
444.79K
+56.97%
Mr. Shlomo Yanai
Mr. Shlomo Yanai
Independent Director
Independent Director
285.99K
+14.08%
Ms. Deborah M. (Deb) Autor
Ms. Deborah M. (Deb) Autor
Independent Director
Independent Director
93.66K
+42.98%

収益内蚳

通貚: USD曎新時刻: Tue, Jan 6
通貚: USD曎新時刻: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
事業別USD
䌚瀟名
収益
比率
Oral solid
180.46M
23.00%
Distribution
96.22M
12.26%
Government label
87.75M
11.19%
Auto-injector
78.94M
10.06%
Central Nervous System
77.63M
9.90%
他の
263.51M
33.59%
䌚瀟から関連デヌタがただ開瀺されおいたせん。
事業別
地域別
事業別USD
䌚瀟名
収益
比率
Oral solid
180.46M
23.00%
Distribution
96.22M
12.26%
Government label
87.75M
11.19%
Auto-injector
78.94M
10.06%
Central Nervous System
77.63M
9.90%
他の
263.51M
33.59%

株䞻

曎新時刻: Sat, Feb 21
曎新時刻: Sat, Feb 21
株䞻統蚈
皮類
株䞻統蚈
株䞻統蚈
比率
Patel (Tushar Bhikhubhai)
15.23%
Patel (Chintu)
8.19%
Patel (Chirag K)
7.10%
Akram (Mahesh)
6.44%
The Vanguard Group, Inc.
5.60%
他の
57.43%
株䞻統蚈
株䞻統蚈
比率
Patel (Tushar Bhikhubhai)
15.23%
Patel (Chintu)
8.19%
Patel (Chirag K)
7.10%
Akram (Mahesh)
6.44%
The Vanguard Group, Inc.
5.60%
他の
57.43%
皮類
株䞻統蚈
比率
Individual Investor
46.21%
Investment Advisor
18.91%
Investment Advisor/Hedge Fund
12.10%
Hedge Fund
11.10%
Private Equity
3.86%
Research Firm
2.42%
Pension Fund
0.49%
Bank and Trust
0.29%
Sovereign Wealth Fund
0.28%
他の
4.33%

機関投資家保有株


曎新時刻: Mon, Dec 8
曎新時刻: Mon, Dec 8
報告期間
機関投資家数
保有株匏数
比率
倉動額
2025Q4
448
154.72M
55.65%
+68.38K
2025Q3
455
154.66M
56.61%
+8.55M
2025Q2
432
145.89M
53.25%
+6.99M
2025Q1
416
138.78M
50.16%
-18.42M
2024Q4
398
129.01M
49.64%
-14.17M
2024Q3
380
143.02M
47.07%
+6.97M
2024Q2
372
135.82M
34.71%
+37.56M
2024Q1
356
97.40M
32.81%
-3.83M
2023Q4
348
89.35M
29.61%
+7.08M
2023Q3
338
82.03M
56.21%
+4.32M
詳现を芋る

株䞻動向


䌚瀟名
保有株匏数
比率
倉動額
倉動率
日付
Patel (Tushar Bhikhubhai)
48.58M
15.45%
-5.00M
-9.33%
Mar 14, 2025
Patel (Chintu)
25.62M
8.15%
--
--
Oct 03, 2025
Patel (Chirag K)
22.13M
7.04%
--
--
Aug 06, 2025
Akram (Mahesh)
20.56M
6.54%
-6.30M
-23.45%
Mar 31, 2025
The Vanguard Group, Inc.
17.90M
5.69%
+403.58K
+2.31%
Sep 30, 2025
Patel (Dipan)
23.83M
7.58%
--
--
Oct 03, 2025
Rubric Capital Management LP
12.33M
3.92%
+624.61K
+5.33%
Sep 30, 2025
TPG Capital, L.P.
12.33M
3.92%
--
--
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
11.34M
3.61%
+697.25K
+6.55%
Sep 30, 2025
Citadel Advisors LLC
5.73M
1.82%
+104.62K
+1.86%
Sep 30, 2025
詳现を芋る

関連ETF


曎新時刻: Sat, Dec 6
曎新時刻: Sat, Dec 6
銘柄名
比率
Invesco Pharmaceuticals ETF
3.08%
State Street SPDR S&P Pharmaceuticals ETF
2.01%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
2%
Invesco Dorsey Wright Healthcare Momentum ETF
0.99%
Invesco Dorsey Wright SmallCap Momentum ETF
0.83%
First Trust NASDAQ Pharmaceuticals ETF
0.78%
First Trust Small Cap Growth AlphaDEX Fund
0.72%
iShares U.S. Pharmaceuticals ETF
0.68%
ProShares Ultra Nasdaq Biotechnology
0.48%
WisdomTree US SmallCap Fund
0.36%
詳现を芋る
Invesco Pharmaceuticals ETF
比率3.08%
State Street SPDR S&P Pharmaceuticals ETF
比率2.01%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
比率2%
Invesco Dorsey Wright Healthcare Momentum ETF
比率0.99%
Invesco Dorsey Wright SmallCap Momentum ETF
比率0.83%
First Trust NASDAQ Pharmaceuticals ETF
比率0.78%
First Trust Small Cap Growth AlphaDEX Fund
比率0.72%
iShares U.S. Pharmaceuticals ETF
比率0.68%
ProShares Ultra Nasdaq Biotechnology
比率0.48%
WisdomTree US SmallCap Fund
比率0.36%

配圓金


過去5幎間の配圓金総支払額は 0.00 米ドルである。
日付
配圓金
暩利確定日
支払日
配圓萜ち日
デヌタなし

株匏分割


日付
配圓萜ち日
皮類
比率
デヌタなし
日付
配圓萜ち日
皮類
比率
デヌタなし
KeyAI
î™